Diagnostics
Todos Medical Ltd. announced positive results from a pre-specified interim analysis of 20 subjects from an ongoing 40-subject outpatient study evaluating the relationship between LymPro Test™ scores with amyloid PET imaging scores.
One problem facing researchers in Alzheimer’s disease is the lack of really good diagnostic tests. Earlier this year, Bill Gates, Jeff Bezos and MacKenzie Bezos teamed to donate over $20 million to the Diagnostics Accelerator, part of the Alzheimer’s Drug Discovery Foundation (ADDF).
Company recognized for its leadership in advancing blood-based tests to diagnose cancer
Biotech and pharma companies strengthen their executive leadership and board positions.
Immigration has been a central concern of President Donald Trump. Since taking office, his administration has put forth a number of policies to restrict the number of immigrants allowed each year, as well as from what nations those immigrants can come.
Two months after taking over as interim chief executive officer of Bay Area-based uBiome, John Rakow is stepping down from the company that has been under scrutiny from the Federal Bureau of Investigation (FBI).
Draper, based in Cambridge, Massachusetts, signed a tissue model development deal with Bristol-Myers Squibb. The companies will collaborate on developing a unique liver tissue model to screen drugs for toxicity.
Biotech and pharma companies from across the globe share pipeline and business updates.
New Diagnostic Test, CERT, Improves Risk Prediction Over Standard Laboratory Tests
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
PRESS RELEASES